scispace - formally typeset
T

Tilo Schwientek

Researcher at University of Cologne

Publications -  38
Citations -  2606

Tilo Schwientek is an academic researcher from University of Cologne. The author has contributed to research in topics: Glycosylation & Gene. The author has an hindex of 22, co-authored 38 publications receiving 2497 citations. Previous affiliations of Tilo Schwientek include University of Copenhagen & Umeå University.

Papers
More filters
Journal ArticleDOI

Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions.

TL;DR: Emerging evidence indicates that formation of many glycosidic linkages is covered by large homologous glycosyltransferase gene families, and that the existence of multiple enzyme isoforms provides a degree of redundancy as well as a higher level of regulation of the glycoforms synthesized.
Journal ArticleDOI

Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.

TL;DR: Chemoenzymatic synthesis of extended MUC1 TR glycopeptides with cancer-associated O-glycosylation using a panel of recombinant human glycosyltransferases is developed and a MAb with similar specificity as the elicited immune response was generated and shown to have the same remarkable cancer specificity.
Journal ArticleDOI

Cloning and Expression of a Proteoglycan UDP-Galactose:β-Xylose β1,4-Galactosyltransferase I A SEVENTH MEMBER OF THE HUMAN β4-GALACTOSYLTRANSFERASE GENE FAMILY

TL;DR: Molecular cloning of β4Gal-T7 should facilitate general studies of its pathogenic role in progeroid syndromes and connective tissue disorders with affected proteoglycan biosynthesis.
Journal ArticleDOI

The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.

TL;DR: Even when C2GnT1 is expressed, the O-glycans added to MUC1 become core 1-dominated structures, provided expression of ST3Gal-I is increased as it is in breast cancer, which indicates a switch to core 2 structures.